Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15-18 Months of Age in Mexico: A Randomized Trial (Q40073773)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15-18 Months of Age in Mexico: A Randomized Trial
scientific article

    Statements

    Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15-18 Months of Age in Mexico: A Randomized Trial (English)
    Flor Irene Rodriguez Melo
    José Juan Renteria Morales
    Abiel Homero Mascareñas De Los Santos
    Enrique Rivas
    Claire Vigne
    Fernando Noriega
    6 January 2017
    602-608

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit